2 March 2021 - Approval is based on the Phase 3 ASPEN trial of Brukinsa compared to ibrutinib. ...
26 February 2021 - Canada's regulator estimates vaccine's efficacy at 62.1 per cent. ...
25 February 2021 - The first and only anti-CGRP treatment with dual indications. ...
25 February 2021 - Medexus Pharmaceuticals announced today that it has initiated the commercial launch of Gleolan in Canada, which had ...
24 February 2021 - Verity-BCG bladder cancer treatment available for Canadian patients in the spring. ...
23 February 2021 - Dupixent is the only biologic medicine approved to treat atopic dermatitis for this patient population. ...
18 February 2021 - Viatris announced today that Health Canada has approved Hulio, and product is now available in Canada. ...
16 February 2021 - Reblozyl, an erythroid maturation agent, is the first and only of its kind approved for use in ...
4 February 2021 - Now available in Canada for the treatment of insomnia in adults. ...
1 February 2021 - This novel formulation provides an alternative administration option for Canadian physicians and their patients. ...
13 January 2021 - Patients aged 70 or younger with previously untreated CLL lived longer without disease progression compared to patients ...
12 January 2021 - Onureg has shown clinically meaningful increase in overall survival for patients. ...
12 January 2021 - Lundbeck is pleased to announce that Vyepti (eptinezumab) has been approved by Health Canada for the preventive ...
11 January 2021 - Bavencio is the first and only maintenance therapy for unresectable locally advanced or metastatic urothelial carcinoma ...
5 January 2020 - KYE Pharmaceuticals today announced an important milestone, Corzyna (ranolazine extended release tablets) has now been approved by ...